Tech Company Financing Transactions
Nano Cures Funding Round
Opulence Capital Management and private investors participated in a $90 million funding round for Nano Cures. This venture round was recorded on 3/16/2021.
Transaction Overview
Company Name
Announced On
3/16/2021
Transaction Type
Venture Equity
Amount
$90,000,000
Round
Undisclosed
Investors
Opulence Capital Management (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the global scale up of its Cures Platform for Covid-19 variants, including vaccines and persistent immunity delivery.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1705 Guadalupe St. 3rd Floor
Austin, TX 78701
USA
Austin, TX 78701
USA
Phone
Undisclosed
Website
Email Address
Overview
The greatest health threats require more than an all-or-nothing approach. Nano represents a multi-layered set of solutions to usher in a new era in proactive, persistent health protection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Papermaster
VP - Bus. Development
Brian Magierski
VP - General Counsel
Zoltan Papp
Browse more venture capital transactions:
Prev: 3/16/2021: insitro venture capital transaction
Next: 3/16/2021: Graphite Bio venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs